Qinghua H. Xia

324 Jingwu Road
Jinan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

Red blood cell-conjugated biomimetic nanomedicine for enhanced therapy of non-small cell lung cancer.

Red blood cell-conjugated biomimetic nanomedicine for enhanced therapy of non-small cell lung cancer.

Journal: Theranostics

Published: July 14, 2025

Prognostic, molecular characterization, and immune infiltration analysis of NUDT16 in clear cell renal cell carcinoma.

Prognostic, molecular characterization, and immune infiltration analysis of NUDT16 in clear cell renal cell carcinoma.

Journal: BMC cancer

Published: July 14, 2025

CDC20 Regulates the Progression of Clear Cell Renal Cell Carcinoma via the Wnt/β-Catenin Signaling Pathway.

CDC20 Regulates the Progression of Clear Cell Renal Cell Carcinoma via the Wnt/β-Catenin Signaling Pathway.

Journal: Genetics research

Published: June 13, 2025

Identification of potential biomarkers and therapeutic targets for underactive bladder based on bioinformatics analysis and experimental validation.

Identification of potential biomarkers and therapeutic targets for underactive bladder based on bioinformatics analysis and experimental validation.

Journal: PloS one

Published: May 15, 2025

FADS3 fuels CcRCC progression via lipid-droplet/TGF-β receptors axis bridging metabolic reprogramming and epithelial plasticity.

FADS3 fuels CcRCC progression via lipid-droplet/TGF-β receptors axis bridging metabolic reprogramming and epithelial plasticity.

Journal: International journal of surgery (London, England)

Published: May 14, 2025

Comprehensive analysis of MGLL as a novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma.

Comprehensive analysis of MGLL as a novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma.

Journal: Frontiers in oncology

Published: March 16, 2025

IGFBP1 orchestrates metabolic reprogramming to drive clear cell renal cell carcinoma progression through NR1H4-mediated lipid homeostasis disruption.

IGFBP1 orchestrates metabolic reprogramming to drive clear cell renal cell carcinoma progression through NR1H4-mediated lipid homeostasis disruption.

Journal: Cancer cell international

Published: February 03, 2025

Optogenetic engineering of lipid droplet spatial organization for tumor suppression.

Optogenetic engineering of lipid droplet spatial organization for tumor suppression.

Journal: Trends in biotechnology

Published: January 13, 2025

Farnesoid X receptor‑driven metabolic plasticity: Bridging physiological adaptation and malignant transformation in lipid handling (Review).

Farnesoid X receptor‑driven metabolic plasticity: Bridging physiological adaptation and malignant transformation in lipid handling (Review).

Journal: International journal of molecular medicine

Published: December 04, 2024

Histone crotonylation in tumors (Review).

Histone crotonylation in tumors (Review).

Journal: Molecular and clinical oncology

Published: November 19, 2024

FADS1, a lipid metabolism-related diagnostic biomarker in KIRC.

FADS1, a lipid metabolism-related diagnostic biomarker in KIRC.

Journal: Discover oncology

Published: October 04, 2024

Identification of KRBA2 as a probable prognostic biomarker correlated with immune infiltration in kidney clear cell carcinoma.

Identification of KRBA2 as a probable prognostic biomarker correlated with immune infiltration in kidney clear cell carcinoma.

Journal: Current urology

Published: June 30, 2023

Showing 1-12 of 54

Last Updated: 09/26/2026